In the advanced stage of cancers, TGF-β can promote tumor growth, invasion, and metastasis by modulating the ECM composition and cell-ECM interactions.44,45 Therefore, by inhibiting TGF-β, SHR-1701 is capable of slowing down the progression of tumor. This evidence concerns the gene TGFB1 and neoplasm.